Cumberland Pharmaceuticals Inc. (CPIX) vs Unicycive Therapeutics, Inc. (UNCY)
A side-by-side comparison of Cumberland Pharmaceuticals Inc. and Unicycive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CPIX
Cumberland Pharmaceuticals Inc.
$7.05HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
UNCY
Unicycive Therapeutics, Inc.
$4.20HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — CPIX vs UNCY
growth of $100 · dividends reinvested · last 5yCPIX +168.7% (+21.9%/yr)UNCY -91.6% (-39.1%/yr)CPIX compounded faster over this window
Log scale — wide-divergence pair
CPIX UNCY
CPIX vs UNCY: by the numbers
- •UNCY is the larger company ($112M vs $106M market cap).
- •Both run net losses; UNCY's is the smaller (0.00% vs -33.92% net margin).
- •CPIX pays a dividend (21.16% yield), while UNCY has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CPIX | UNCY |
|---|---|---|
| P/S ratio | 3.38 | N/A |
| P/B ratio | 6.06 | 2.10 |
Profitability
| Metric | CPIX | UNCY |
|---|---|---|
| Gross margin | 83.37% | 0.00% |
| Operating margin | -6.27% | 0.00% |
| Net margin | -33.92% | 0.00% |
| ROE | -60.82% | -66.12% |
| ROIC | -34.77% | -62.15% |
Dividends
| Metric | CPIX | UNCY |
|---|---|---|
| Dividend yield | 21.16% | N/A |
Growth (annualized)
| Metric | CPIX | UNCY |
|---|---|---|
| Revenue CAGR (5Y) | 3.53% | N/A |
| Total return CAGR (5Y) | 25.62% | -32.14% |
Frequently asked
- Does CPIX or UNCY pay a bigger dividend?
- CPIX pays a dividend (21.16% yield), while UNCY has no payments in the available dividend history.
- How have CPIX and UNCY total returns compared?
- Over the past 5 years, CPIX delivered 25.62% and UNCY delivered -32.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cumberland Pharmaceuticals dividend yieldCumberland Pharmaceuticals ROEUnicycive Therapeutics ROECumberland Pharmaceuticals operating marginUnicycive Therapeutics operating marginCumberland Pharmaceuticals revenue growthUnicycive Therapeutics revenue growthCumberland Pharmaceuticals free cash flowUnicycive Therapeutics free cash flow
Cumberland Pharmaceuticals & Unicycive Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.